RecruitingPhase 3NCT07780656
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
Sponsor: GlaxoSmithKline
West Point, UT · +3 more sites